Segall Bryant & Hamill, LLC Bioventus Inc. Transaction History
Segall Bryant & Hamill, LLC
- $6.35 Billion
- Q1 2025
A detailed history of Segall Bryant & Hamill, LLC transactions in Bioventus Inc. stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 49,547 shares of BVS stock, worth $362,188. This represents 0.01% of its overall portfolio holdings.
Number of Shares
49,547
Previous 352,629
85.95%
Holding current value
$362,188
Previous $3.7 Million
87.76%
% of portfolio
0.01%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding BVS
# of Institutions
156Shares Held
44.9MCall Options Held
252KPut Options Held
72.5K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$95.2 Million31.61% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$50.7 Million28.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.03MShares$29.4 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$18 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$17.3 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $451M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...